China Diabetes Market Report 2024-2032: China Currently has the Highest Number of Diabetics in the World
22 juil. 2024 04h22 HE
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "China Diabetes Market Report: 2024-2032" report has been added to ResearchAndMarkets.com's offering.The China diabetes market size reached US$ 4.7...
Global Diabetes and Obesity Therapeutics Market Research 2024 2028: GLP-1 RA Drug Class, Combination Therapies, and Digital Convergence for Affordable Disease Management Drive Growth
18 juil. 2024 04h48 HE
|
Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024 2028" report has been added to ResearchAndMarkets.com's offering. This study...
Diabetes Pen Market Insights, Competitive Landscape and Market Forecast 2024-2030
11 juil. 2024 11h17 HE
|
Research and Markets
Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "Diabetes Pen - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The...
Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity Market Analysis 2024 - The Use of GLP-1R Agonists is Expected to Quadruple in the Next 10 Years, at a CAGR of 14.9%
04 juin 2024 04h17 HE
|
Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis" report has been...
Global Diabetes Drug Analysis Report 2024: A $107.02 Billion Market by 2032 Driven by Novo Nordisk, AstraZeneca, Biocon, Sanofi, Eli Lilly, Johnson & Johnson, Bristol Myers Squibb, Novartis
24 mai 2024 07h07 HE
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Global Diabetes Drug Market Report by Drug class, Diabetes types, Route of Administration, Distribution Channels, Region and Company Analysis 2024-2032"...
Octreotide Market Size, Forecast, and Developments Through 2032
03 mai 2024 05h46 HE
|
Research and Markets
Dublin, May 03, 2024 (GLOBE NEWSWIRE) -- The "Octreotide Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. The report provides an...
Global Diabetes Drugs Market to Witness an Upsurge in Growth by 2030, Examines DelveInsight | Key Companies in the Market - Sanofi, AstraZeneca, Pfizer, Johnson & Johnson, Novartis, Merck & Co., Novo Nordisk, Eli Lilly and Company, Biocon
23 avr. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, April 23, 2024 (GLOBE NEWSWIRE) -- Global Diabetes Drugs Market to Witness an Upsurge in Growth by 2030, Examines DelveInsight | Key Companies in the Market - Sanofi, AstraZeneca,...
Global Prediabetes Treatment Market Analysis & Forecast Report 2024-2034
23 avr. 2024 04h01 HE
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Global Prediabetes Treatment Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...
Developed by Ricardio - Dutogliptin (REC-01) Drug Research Report 2024: A Potent and Selective Inhibitor of Dipeptidyl Deptidase 4 (DPP4) - Market Size, Forecast, and Emerging Insight 2019-2032
16 avr. 2024 04h29 HE
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Dutogliptin Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering."Dutogliptin Market Size,...
Global Prediabetes Market Analysis Report 2024-2030, Featuring Valbiotis, RESVERLOGIX, Caelus Health, SciMar, Boston Therapeutics, Aphaia Pharma, AstraZeneca and Bristol-Myers Squibb
15 avr. 2024 11h18 HE
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Global Prediabetes Market Size, Share & Trends Analysis Report by Drug Class (Diguanide, Thiazolidinediones), Age Group (Children, Adult), Region,...